'The Future Strategies of Cervical Cancer Prevention: What Do We Need to Do Now to Prepare' Forum Facilitates Discussion on the Prevention of Cervical
Cancer in the HPV Vaccine Era
CHICAGO, Sept. 9 /PRNewswire/ -- The Society of Gynecologic Oncologists (SGO) is hosting a Cervical Cancer Prevention Forum on September 12-13, 2008 at the Hotel SAX in Chicago, IL. Approximately 50 key thought leaders will be in attendance to discuss the undefined areas of cervical cancer prevention, identify future research needs and establish follow-up initiatives for the future.
Since the introduction of the prophylactic HPV vaccines, healthcare providers have been faced with a host of questions and challenges concerning the clinical, public health, policy and economic issues regarding the prevention of cervical cancer. SGO, whose vision is "to eradicate gynecologic cancers", felt it was the opportune time to facilitate a larger discussion to answer these mounting questions and provide direction for the future.
"The HPV vaccine is a major technologic advance that has shown considerable promise in preventing the incidence of cervical cancer," states SGO President, Thomas Burke, MD. "As a result, we need to reevaluate the status of cervical cancer by identifying what is needed to more forward to eradicate this women's disease."
SGO invited key representatives from the various populations of clinicians, scientists, physicians and the public policy sector to participate in an informal, interactive discussion moderated by SGO members Levi Downs, MD, Mark Einstein, MD, Thomas Herzog, MD, Warner Huh, MD and Stewart Massad, MD.
"We believe the results of this meeting will have a tremendous impact on the future of cervical cancer prevention," asserts Dr. Herzog, Chair of the SGO Education Committee. "The Forum will redefine clinical, public health, policy and economic issues, as well as create a comprehensive summary to identify future research needs and initiatives."
"There is no time better than now for SGO to host a Forum on the future of cervical cancer prevention," adds Dr. Einstein. "The medical society as a whole has come to a crossroads on how to continue into the future, and SGO is taking a proactive role by leading the future of women's health on a new path."
The Forum's discussions will be captured and shared with the public in the form of a whitepaper to be published soon after the meeting. The whitepaper will detail the Forum's follow-up initiatives, as well as future research needs for attendees and key stakeholder groups working to prevent cervical cancer. The ensuing whitepaper is intended to provide a composite view of the future of cervical cancer screening, prevention and treatment. Professionals dedicated to the prevention of cervical cancer are strongly encouraged to read this summary when released.
The Society of Gynecologic Oncologists (SGO) is a national medical
specialty society for physicians trained in the comprehensive management of
women's cancers. The Society's membership, totaling more than 1230, is
primarily comprised of gynecologic oncologists --
obstetrician/gynecologists with three -- four years of additional,
intensive training in the specific study of gynecologic cancers. SGO
members provide medical and surgical care to women with ovarian cancer,
cervical cancer, endometrial cancer, vulvar cancer, and vaginal cancer.
They are trained in chemotherapy and radiation therapy administration,
supportive care, and surgery in order to provide comprehensive patient
care. More information on gynecologic oncology, the SGO, and its members
can be found at http://www.sgo.org.
For more information please contact:
Society of Gynecologic Oncologists
Phone: 312/235-4060 x244
|SOURCE Society of Gynecologic Oncologists|
Copyright©2008 PR Newswire.
All rights reserved